Bharat Biotech, ICMR announce interim results from Phase 3 trials of COVAXIN
It demonstrates overall interim clinical efficacy of 78 per cent and 100 per cent efficacy against severe COVID-19 disease
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Phase 3 trials
Moderna begins Phase 3 trials of its COVID-19 vaccine candidate
The randomised, placebo-controlled trial is expected to include approximately 30,000 participants in the US